Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts


  HIV Infection

  Free Subscription


21.04.2025

3 AIDS
2 AIDS Res Hum Retroviruses
1 Am J Med
3 Antivir Ther
1 BMC Pediatr
1 BMJ
4 Clin Infect Dis
2 HIV Med
5 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Immunol
2 J Infect Dis
2 J Med Virol
2 J Virol
3 Lancet
1 N Engl J Med
1 Nat Med
1 Nature
5 Pediatr Infect Dis J
1 Pediatrics
3 PLoS One
1 PLoS Pathog
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. OH TK, Song KH, Heo E, Song IA, et al
    Association between HIV and cancer risk: a nationwide, population-based cohort study.
    AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004210.
    PubMed         Abstract available

  2. NAMPOTA-NKOMBA N, Mohanty K, Adebiyi R, Ekeh C, et al
    Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIV.
    AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004209.
    PubMed         Abstract available

  3. GLENN JS, Bennett A, Mackie N, Lyall H, et al
    The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
    AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  4. CHEN M, Chen H, Dai J, Dong L, et al
    Identification of a Novel Second-Generation HIV-1 Circulating Recombinant Form (CRF174_0708) Arising from CRF07_BC and CRF08_BC in Yunnan, China.
    AIDS Res Hum Retroviruses. 2025 Apr 14. doi: 10.1089/aid.2025.0022.
    PubMed         Abstract available

  5. YU M, Wang X, Jia L, Han J, et al
    Sequence Notes: Identification of Two New CRF01_AE/CRF07_BC Recombinants in Men Who Have Sex with Men Populations in Beijing, China.
    AIDS Res Hum Retroviruses. 2025 Apr 14. doi: 10.1089/aid.2024.0098.
    PubMed         Abstract available


    Am J Med

  6. JOSEPH S, Borja Y, Gavathas P, Ammar H, et al
    It's not always Molluscum: A case of disseminated Cryptococcosis.
    Am J Med. 2025 Apr 12:S0002-9343(25)00233-5. doi: 10.1016/j.amjmed.2025.
    PubMed        


    Antivir Ther

  7. ELEJE GU, Usman HA, Onubogu CU, Fiebai PO, et al
    Seroprevalence, seroconversion, and mother-to-child transmission of dual and triplex infections of HIV, HBV, and HCV among Nigerian obstetric population: A national multicentre prospective cohort study.
    Antivir Ther. 2025;30:13596535251333259.
    PubMed         Abstract available

  8. PALLANZA M, Thoueille P, Briki M, Alves Saldanha S, et al
    Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine.
    Antivir Ther. 2025;30:13596535251335080.
    PubMed         Abstract available

  9. LABATE L, Rossetti B, Russo C, Cassol C, et al
    Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database.
    Antivir Ther. 2025;30:13596535251317054.
    PubMed         Abstract available


    BMC Pediatr

  10. M Y, Vamja R, Parmar PA, Makwana N, et al
    Diagnostic utility of haematological parameters for tuberculosis in children living with HIV (0-14 years): a retrospective cohort study.
    BMC Pediatr. 2025;25:301.
    PubMed         Abstract available


    BMJ

  11. DYER O
    Trump's HIV cuts bite hard in Africa and at home.
    BMJ. 2025;389:r771.
    PubMed        


    Clin Infect Dis

  12. KIM S, Pelissari DM, Harada LO, Sanchez M, et al
    Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
    PubMed         Abstract available

  13. BREGER TL, Westreich DJ, Edmonds A, Edwards JK, et al
    Incidence of statin initiation among people with and without HIV in the US: a prospective observational study.
    Clin Infect Dis. 2025 Apr 17:ciaf207. doi: 10.1093.
    PubMed         Abstract available

  14. MONTEPIEDRA G, Aaron L, Theron G, McCarthy K, et al
    Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics.
    Clin Infect Dis. 2025 Apr 16:ciaf198. doi: 10.1093.
    PubMed         Abstract available

  15. KULIK GL, Mollner DC, Barbera L, Walker J, et al
    Application of Pragmatic Criteria to Assessments of Frailty and Physical Function among People with HIV.
    Clin Infect Dis. 2025 Apr 15:ciaf193. doi: 10.1093.
    PubMed         Abstract available


    HIV Med


  16. Correction to "Perception of medical care among women living with HIV aged 40 years or older-a European-wide survey".
    HIV Med. 2025 Apr 14. doi: 10.1111/hiv.70032.
    PubMed        

  17. ADMASSU Z, Logie CH, Vahedi L, Underhill A, et al
    Longitudinal associations between social determinants of health and well-being among women living with HIV in Canada: A latent class analysis.
    HIV Med. 2025 Apr 14. doi: 10.1111/hiv.70031.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  18. CRANE HM, Ruderman SA, Nance RM, Drumright LN, et al
    Approaches to optimally target frailty screening among people with HIV in clinical care: findings from the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS).
    J Acquir Immune Defic Syndr. 2025 Apr 17. doi: 10.1097/QAI.0000000000003688.
    PubMed         Abstract available

  19. NAMPOTA-NKOMBA N, Buchwald A, Nyirenda OM, Mkandawire FA, et al
    Association between Maternal HIV and Adverse Birth Outcomes in the Era of Universal Antiretroviral Therapy in Malawi.
    J Acquir Immune Defic Syndr. 2025 Apr 17. doi: 10.1097/QAI.0000000000003685.
    PubMed         Abstract available

  20. NDONGO FA, Tejiokem MC, Penda CI, Ndiang ST, et al
    IMMUNOLOGICAL AND VIROLOGIC OUTCOMES WITHIN TEN YEARS OF COMBINED ANTIRETROVIRAL THERAPY INITIATED BEFORE ONE YEAR OF AGE IN CAMEROONIAN CHILDREN WITH PERINATAL HIV.
    J Acquir Immune Defic Syndr. 2025 Apr 17. doi: 10.1097/QAI.0000000000003687.
    PubMed         Abstract available

  21. MAROTTA PL, Humphries D, Escudero D, Katz DA, et al
    Strengthening the US Health Workforce to End the HIV Epidemic: Lessons Learned From 11 EHE Jurisdictions: Erratum.
    J Acquir Immune Defic Syndr. 2025 Apr 18. doi: 10.1097/QAI.0000000000003683.
    PubMed        

  22. HUMPHRIES DL, Audet CM, Balasubramanian BA, Benbow N, et al
    Building the Road to End the HIV Epidemic Through Coordinating and Capacity-Building Hubs to Enhance the Science of HIV Implementation REsearch (CHESHIRE): Reflections and Directions: Erratum.
    J Acquir Immune Defic Syndr. 2025 Apr 18. doi: 10.1097/QAI.0000000000003684.
    PubMed        


    J Clin Invest

  23. PAL PB, Iyer SS
    Transient pain and long-term gain: adjuvant dose directs immune memory.
    J Clin Invest. 2025;135:e190524.
    PubMed         Abstract available


    J Immunol

  24. DING C, Chen Q, Shi Y, Liu J, et al
    Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination.
    J Immunol. 2025 Apr 15:vkae040. doi: 10.1093.
    PubMed         Abstract available


    J Infect Dis

  25. RONN MM, Chesson HW, Grad YH, Reitsma M, et al
    The influence of epidemiological context on the success of partner notification programs: analysis of gonorrhea transmission dynamics.
    J Infect Dis. 2025 Apr 18:jiaf206. doi: 10.1093.
    PubMed         Abstract available

  26. WANG Y, Brichacek B, Dubrovsky L, Pushkarsky T, et al
    Increased atherosclerosis in HIV-infected humanized mice is caused by a single viral protein, Nef.
    J Infect Dis. 2025 Apr 16:jiaf192. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  27. WEI Q, Chen L, Yin Y, Pai M, et al
    Analysis of Blood Microbiome From People Living With HIV and Donors by 16S rRNA Metagenomic Sequencing.
    J Med Virol. 2025;97:e70341.
    PubMed         Abstract available

  28. DEMIRDJIAN S, Naik V, Margot N, Falkard B, et al
    Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV Clinical Isolates.
    J Med Virol. 2025;97:e70340.
    PubMed         Abstract available


    J Virol

  29. MOORAD R, Peng A, Landis J, Pluta LJ, et al
    Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV).
    J Virol. 2025 Apr 16:e0195024. doi: 10.1128/jvi.01950.
    PubMed         Abstract available

  30. GROVES NS, Clark AR, Aguilar RS, Hikichi Y, et al
    A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation.
    J Virol. 2025 Apr 15:e0210524. doi: 10.1128/jvi.02105.
    PubMed         Abstract available


    Lancet

  31. UNEMO M, Wi T
    Gepotidacin shows promise for the treatment of uncomplicated gonorrhoea.
    Lancet. 2025 Apr 11:S0140-6736(25)00680-4. doi: 10.1016/S0140-6736(25)00680.
    PubMed        

  32. ROSS JDC, Wilson J, Workowski KA, Taylor SN, et al
    Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
    Lancet. 2025 Apr 11:S0140-6736(25)00628-2. doi: 10.1016/S0140-6736(25)00628.
    PubMed         Abstract available

  33. NDEMBI N, Karuna S, Cowden J, Cagigi A, et al
    Accelerating vaccine development in Africa: lessons from HIV research.
    Lancet. 2025 Apr 10:S0140-6736(25)00564-1. doi: 10.1016/S0140-6736(25)00564.
    PubMed        


    N Engl J Med

  34. RASKO JEJ, Samelson-Jones BJ, George LA, Giermasz A, et al
    Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.
    N Engl J Med. 2025;392:1508-1517.
    PubMed         Abstract available


    Nat Med


  35. Extreme inequities in access to HIV treatment in Malawi.
    Nat Med. 2025 Apr 15. doi: 10.1038/s41591-025-03676.
    PubMed        


    Nature

  36. MALLAPATY S
    25 million deaths: what could happen if the US ends global health funding.
    Nature. 2025 Apr 17. doi: 10.1038/d41586-025-01191.
    PubMed        


    Pediatr Infect Dis J

  37. WACHARACHAISURAPOL N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2025;44:428-430.
    PubMed         Abstract available

  38. PATTEN G, Malateste K, Bolton Moore C, Sipambo N, et al
    Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.
    Pediatr Infect Dis J. 2025 Apr 4. doi: 10.1097/INF.0000000000004819.
    PubMed         Abstract available

  39. PRABHUDAS-STRYCKER K, Waugh M, Bates B, Weaver B, et al
    Postpandemic Trends and Missed Opportunities in Prevention and Diagnosis of Pediatric HIV.
    Pediatr Infect Dis J. 2025 Apr 15. doi: 10.1097/INF.0000000000004822.
    PubMed         Abstract available

  40. ANTWI S, Enimil A, Yang H, Martyn-Dickens C, et al
    Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection.
    Pediatr Infect Dis J. 2025 Apr 10. doi: 10.1097/INF.0000000000004831.
    PubMed         Abstract available

  41. LOMBAARD J, Moolasart V, Lutaakome J, Van Solingen-Ristea R, et al
    Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naive Children With HIV >/=6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study.
    Pediatr Infect Dis J. 2025 Apr 18. doi: 10.1097/INF.0000000000004828.
    PubMed         Abstract available


    Pediatrics

  42. POOSER M, Yuan Y, Karki S, O'Callaghan K, et al
    The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019.
    Pediatrics. 2025 Apr 14:e2024067348. doi: 10.1542/peds.2024-067348.
    PubMed         Abstract available


    PLoS One

  43. ALLY ZM, Moshi L, Musoke R, Mbwana MS, et al
    Trend of genital ulcers and discharge and associated factors among survey respondents in Tanzania, 2004-2022: Analysis of demographic health surveys.
    PLoS One. 2025;20:e0319467.
    PubMed         Abstract available

  44. KOAY WLA, Ganesan K, Unternaher J, Morrison S, et al
    Implementation of adolescent HIV screening in two urban pediatric emergency departments in the United States.
    PLoS One. 2025;20:e0321473.
    PubMed         Abstract available

  45. KITAW TA, Azmeraw M, Abate BB, Tilahun BD, et al
    The burden of HIV/AIDS in Ethiopia: Unveiling 30 years of trends in incidence, mortality, and disability-insights from the Global Burden of Disease study (1990-2021).
    PLoS One. 2025;20:e0321024.
    PubMed         Abstract available


    PLoS Pathog

  46. BUCHANAN LB, Shao Z, Galiwango RM, Constable S, et al
    HIV-associated penile anaerobes disrupt epithelial barrier integrity.
    PLoS Pathog. 2025;21:e1013094.
    PubMed         Abstract available


    Virology

  47. BELL JT, Zhang X
    The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries.
    Virology. 2025;608:110527.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.